Skip to main navigation

4D Molecular Therapeutics

    About

  • About
    • Company Overview
    • Purpose & Strategy
    • FOUNDERS
    • Leadership Team
    • Board of Directors
    • CONTACT US
  • Technology

  • Technology
    • GENE THERAPY
    • Conventional Vectors
    • 4DMT Therapeutic Vector Evolution
    • Scientific Presentations
  • Product Pipeline

  • Product Pipeline
    • Pipeline Overview
    • Ophthalmology
    • Cardiology
    • Pulmonology
  • Patients & Advocacy

  • Patients
    • Overview
    • Clinical Trials
      • XLRP 4D-125
      • XLRP Natural History
      • CHM 4D-110
      • FABRY 4D-310
    • Advocacy Partners
    • Community Outreach
    • Patient Stories
    • Resources
  • IR Nav

  • Investors
    • Overview
    • Events & Presentations
    • Press Releases
    • SEC Filings
    • Stock Information
    • Analyst Coverage
    • Corporate Governance
  • Careers

  • Careers and Culture
    • Overview and Openings
    • Competitive Compensation
    • Benefits, Balance and Well-being
    • Growth and Development
    • Culture and Community
Menu

Investors & Media

Event Details

4D-710 Phase 1/2 Interim Clinical Data Conference Call

November 03, 2022 at 4:30 PM EDT

Click here for webcast

Contacts

Media

Katherine Smith
Evoke Canale
katherine.smith@evokegroup.com
619-849-5378

Investors

August Moretti
Chief Financial Officer
amoretti@4dmt.com
 

Request Email Alerts

 
Share

Social icons

Linkedin Facebook

    About

  • About
  • Technology

  • Technology
  • Product Pipeline

  • Product Pipeline
  • Patients & Advocacy

  • Patients
  • IR Nav

  • Investors
  • Careers

  • Careers and Culture
  • Home

  • Home
  • Terms of Use

  • Terms of Use
© 2023 4D Molecular Therapeutics, All Rights Reserved